Goldman Wins ASCPT Award
Jennifer Goldman, MD, Infectious Diseases, is the recipient of the Leon I. Goldberg Early Investigator Award from the American Society for Clinical Pharmacology & Therapeutics (ASCPT). She will be honored at the 2020 annual ASPCT meeting for her contributions in clinical pharmacology and translational science.
Dr. Goldman's work centers on adverse drug reactions in children and her current RO1 is focused specifically on the trimethoprim component in patients who develop an idiosyncratic drug reaction while receiving trimethoprim-sulfamethoxazole. Dr. Goldman was selected among many highly qualified candidates and this award speaks to her valuable contributions in the field of clinical pharmacology.
Children’s Mercy Kansas City is ranked as one of “America's Best Children's Hospitals” in all 10 specialties rated by U.S. News & World Report and has received MagnetTM recognition for excellence in nursing services four consecutive times. With 366 licensed beds and a medical staff of more than 750 pediatric subspecialists, we care for children from all 50 states and from around the world. In addition, our leadership in pediatric genomic medicine and individualized pediatric therapeutics is driving research and innovation in neonatology, nephrology, endocrinology, gastroenterology, neurology, heart, cancer and other subspecialties to transform outcomes for children. Children’s Mercy also is nationally recognized for innovation in psychosocial care and creating a family-centered environment focused on the unique needs of hospitalized children and their families. Our love for children powers everything we do, inspiring our research, innovations and our everyday care. Because love has no limits. And with it, neither do we.